Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Clin Rheumatol

Search In Journal Title:

Abbravation: Clinical Rheumatology

Search In Journal Abbravation:

Publisher

Springer London

Search In Publisher:

DOI

10.1007/s002100100483

Search In DOI:

ISSN

1434-9949

Search In ISSN:
Search In Title Of Papers:

Prevalence of rheumatic diseases in Raramuri peopl

Authors: Danyella Del Río Nájera Natalia Santana Ingris PeláezBallestas Susana A GonzálezChávez Celia M QuiñonezFlores César PachecoTena
Publish Date: 2016/03/08
Volume: 35, Issue: 1, Pages: 43-52
PDF Link

Abstract

This study aimed to determine the prevalence of musculoskeletal MSK pain and rheumatic diseases in the Raramuri population also known as Tarahumaras who are an indigenous group in the northern state of Chihuahua in Mexico We used the CommunityOriented Program for Control of Rheumatic Diseases COPCORD methodology An analytical crosssectional study was conducted including indigenous Raramuri aged ≥18 years from communities settled in Chihuahua City Subjects with positive MSK pain were evaluated by primary care physicians and rheumatologists Demographic and occupational factors such as gender and job type associated with rheumatic disease were investigated A total of 380 indigenous Raramuri mean age 336 ± 131 years 379  male were interviewed Seventysix individuals 20  reported MSK pain in the last 7 days Pain intensity was reported as “severe” and “the most severe” in 30  of the cases Fiftysix individuals 147  reported pain in the past and 86 226  had either past or current pain The prevalence of rheumatic diseases was 105  Diagnosed diseases were osteoarthritis 66  low back pain 16  spondyloarthritis 08  rheumatoid arthritis 05  nonspecific arthritis 05  rheumatic regional pain syndromes 03  and fibromyalgia 03  Rheumatic disease was associated with the following variables age odds ratio OR 104 95  confidence interval CI 102–108 p = 0006 family history of rheumatic symptoms OR 69 95  CI 26–187 p  0001 and Health Assessment QuestionnaireDisability Index OR 289 95  CI 28–2897 p  0001 A high prevalence of nontraumatic MSK pain suggests the need for a rheumatic disease prevention program in the Raramuri people in Chihuahua MexicoRheumatic diseases represent a global problem for both patients and healthcare providers Developing countries are particularly vulnerable because of insufficient and delayed diagnosis of these diseases 1 2 Pain in the musculoskeletal MSK system is characteristic of rheumatic diseases and additionally may lead to disability Individuals suffering from rheumatic disorders have a significant reduction in both their quality of life and life expectancy 3The CommunityOriented Program for Control of Rheumatic Diseases COPCORD was founded by the World Health Organization and International League of Associations for Rheumatology This program emerged as a strategy to define the epidemiologic landscape of rheumatic diseases in developing countries COPCORD provides a screening tool for rheumatic diseases for lowcost community studies 2 4The COPCORD methodology has already been used to assess the prevalence of MSK disorders and rheumatic diseases in Latin American countries 5 6 7 8 9 In Mexico this methodology has been applied in a number of distinct geographic regions 3 10 11 12 13 Previous studies focused mostly on Mexican mestizo populations COPCORD was also applied in more susceptible populations including indigenous groups 7 14 A culturesensitive adaptation and validation of this methodology was performed in Latin American indigenous populations It included Warao Kariña and Chaima Venezuela Mixteco MayaYucateco and Raramuri Mexico and Qom Argentina groups 15Mexico has a multicultural environment that includes many indigenous groups 16 17 The Raramuri people also known as Tarahumaras are a minority indigenous people living in the northern region of Mexico The main location of this group is in the states of Chihuahua Durango and Sonora The Raramuri people living in Chihuahua comprise a group of 158527 people which is almost 5  of the state’s total population 17The Raramuri people are considered as a vulnerable group 18 Their main environment is the “Sierra Tarahumara” which is a rural region composed of mountains canyons and thick forests The terrain is vast and inaccessible resulting in poor Raramuri health status given their very limited or absent access to healthcare facilities 18 19 20 There is a high rate of infant mortality because of infant malnutrition and susceptibility to various infectious diseases 20 Although poor health conditions have been recognized to our knowledge the prevalence of chronic illnesses including MSK disorders and rheumatic diseases has not been reported in the Raramuri indigenous population However it has been found that 37  of this population in Chihuahua State has some kind of physical impairment 17 which could be associated with MSK disorders Detailed information regarding the prevalence of rheumatic diseases could help to create specific prevention programs and also improve healthcare provision in this group Thus the aim of this study was to estimate the prevalence of MSK regional pain syndromes neck shoulder etc and defined rheumatic diseases in Raramuri individuals over 18 years of age living in Chihuahua City as well as to determine the factors associated with the presence of these rheumatic diseasesA crosssectional communitybased study was conducted using the COPCORD methodology The screening tool applied was the COPCORD questionnaire which has been adapted and validated for the Raramuri people 15 The subjects included in the study were aged 18 years or older and belonged to the Raramuri community They were invited to take part in the study and voluntarily gave consent to participate in the surveyThe COPCORD questionnaire 15 included items related to 1 sociodemographic factors 2 comorbidities 3 symptoms pain swelling and stiffness 4 pain characteristics period of time last 7 days or historic pain intensity five options in the Likert scale ranging from none to more severe pain and location and 5 treatment use of conventional and nonconventional medicine Moreover information about disability and work biomechanical loading was collected from the subjects affected by MSK pain using the Health Assessment QuestionnaireDisability Index HAQDI 21 and the mechanical stress dynamic and static questionnaire 22 respectively The mechanical stress questionnaire considers the kind of work that individuals have done throughout their life and identifies the types of positions and movements performed during work Both questionnaires were applied by trained personnel


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases
  2. The virtuoso foot
  3. Responsiveness of the DASH score in surgically treated basal joint arthritis of the thumb: preliminary results
  4. RAPID3 scores and hand outcome measurements in RA patients: a preliminary study
  5. Bone mineral density in children with familial Mediterranean fever
  6. Chorea as a side effect of gabapentin (Neurontin®) in a patient with complex regional pain syndrome Type 1
  7. Risk factors in transient osteoporosis: a retrospective study on 23 cases
  8. Outcome of reactive arthritis after an extensive Finnish waterborne gastroenteritis outbreak: a 1-year prospective follow-up study
  9. Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement
  10. The autonomic nervous system in systemic sclerosis. A review
  11. Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay
  12. Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan
  13. Rheumatoid arthritis: should we shift the focus from “Treat to Target” to “Treat to Work?”
  14. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis
  15. Severe deficiency of 25-hydroxyvitamin D 3 (25-OH-D 3 ) is associated with high disease activity of rheumatoid arthritis
  16. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren’s syndrome
  17. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)
  18. Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared
  19. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge
  20. Group visits for rheumatoid arthritis patients: a pilot study
  21. Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis
  22. The impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
  23. Two cases demonstrating thalidomide’s efficacy in refractory lupus nephritis
  24. Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic
  25. The challenge of profound hypoglycorrhachia: two cases of sarcoidosis and review of the literature
  26. Chronic intestinal pseudo-obstruction in patients with systemic lupus erythematosus: report of four cases
  27. Relationship of Q angle and joint hypermobility and Q angle values in different positions
  28. Osteoarthritis of the hip or knee: which coexisting disorders are disabling?
  29. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels
  30. T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet’s disease
  31. Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
  32. Oxidative status in rheumatoid arthritis
  33. Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey
  34. Follicular bronchiolitis, an unusual cause of haemoptysis in giant cell arteritis
  35. Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature
  36. Vitamin D and systemic lupus erythematosus: state of the art
  37. Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America
  38. Clostridium difficile : an under-recognized cause of reactive arthritis?
  39. Clinical utility of magnetic resonance angiography (MRA) in the diagnosis and treatment of Takayasu’s arteritis
  40. A systematic review of homoeopathy for the treatment of fibromyalgia
  41. Do hip OA patients referred to orthopedic surgeons by general practitioners and rheumatologists differ?
  42. The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus
  43. Antistreptococcal Response is Exaggerated in Children with Familial Mediterranean Fever
  44. High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register
  45. Beware of the biologicals—hospitals may die: the Rheumatism Foundation Hospital, Heinola, Finland (1951–2010)
  46. Patterns of pain in Paget’s disease of bone and their outcomes on treatment with pamidronate
  47. QT dispersion in uncomplicated familial Mediterranean fever
  48. Ultrasonographic evaluation of the muscle architecture in patients with systemic lupus erythematosus
  49. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin
  50. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis
  51. Autonomic dysfunction in psoriatic arthritis
  52. Exercise therapy for patients with diffuse idiopathic skeletal hyperostosis
  53. Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients
  54. The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis
  55. Increased expression of IL - 28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
  56. Contrast-enhanced power Doppler sonography of knee synovitis in rheumatoid arthritis: assessment of therapeutic response
  57. Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus
  58. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome
  59. Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects
  60. Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis
  61. Serum galectin-3 level in systemic sclerosis
  62. Non-rheumatoid erosive arthritis associated with type I hereditary angioedema
  63. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
  64. Familial Mediterranean fever responds well to infliximab: single case experience
  65. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
  66. The role of PET/CT in Cogan’s syndrome
  67. Treatment of osteoporosis in renal insufficiency
  68. STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population

Search Result: